Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022

Abstract

A nationwide survey of SARS-CoV-2 antinucleocapsid seroprevalence among blood donors in Japan revealed that, as of November 2022, infection-induced seroprevalence of the population was 28.6% (95% CI 27.6%–29.6%). Seroprevalence studies might complement routine surveillance and ongoing monitoring efforts to provide a more complete real-time picture of COVID-19 burden.

Keywords

• SARS-CoV-2
• COVID-19
• respiratory infections
• viruses
• zoonoses
• seroprevalence